Sunday, Aug 31st
Last update06:30:57 AM GMT
Drug companies are blocking or delaying the entry of cheaper generic medicines into the EU, pushing up medicine bills, the European Commission has said.
Their actions cost EU healthcare providers 3bn euros ($3.9bn; £2.5bn) in savings between 2000 and 2007, it said.
 The U.S. is seeing a late summer surge in COVID-19 cases, tracking from the Centers for... |
| ||
 The US’s top public health agency was plunged into chaos on Wednesday after the Trump administration... |
 Vinay Prasad, a top vaccine regulator ousted from the Food and Drug Administration (FDA) late last... |
